Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Scalp Disorders Clinical Trials

A listing of Scalp Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (11) clinical trials

This study will be conducted to evaluate the therapeutic bioequivalence of a TEST formulation of calcipotriene hydrate and betamethasone dipropionate topical suspension 0.005%/0.064% to the RLD.

Phase

Scalp Psoriasis Research Study This study evaluates an investigational topical medication for Scalp Psoriasis.

Phase N/A

We are conducting a research study evaluating the safety and effectiveness of an investigational shampoo for scalp psoriasis. Qualified participants will receive study related exams and study medication at no charge. Please contact us today!

Phase N/A

A Random, Double- blind, Parallel-group, Vehicle -controlled, Multicenter Study Comparing TOLMAR Calcipotriene Hydrate and Betamethasone Diproprionate Topical Suspension 0.005%0.064% to Reference Listed Drug in the Treatment of Scalp Psoriasis.

Phase N/A

At least 18 years of age Mild to severe psoriasis Only three visits Up to $150 for time and travel

Phase N/A

Patient Inclusion Criteria: 18+ years of age Diagnosis of stable plaque psoriasis Mild to moderate on trunk and/or limbs Patient Exclusion Criteria: Current diagnosis of guttate, erythrodermic or pustular psoriasis

Phase

Medical Center for Clinical Research is enrolling individuals who suffer from scalp psoriasis in a research study comparing an investigational medication to an already approved product.   Other Details: Qualified participants receive: -Study-related medication at no cost -Study-related medical exams at no cost -Compensation up to $150 for time and ...

Phase N/A

To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin

The trial is a multicentre, randomised, double-blind, placebo controlled phase 2 trial. 60 healthy bald male subjects diagnosed with alopecia, who are between 18 and 55 years old and provide written informed consent will be eligible for inclusion. The trial period will consist of a screening period of up to ...

Phase